Published in Nature Portfolio’s npj Digital Medicine, China’s Future Doctor Team’s New Benchmark Aims to Define What “Safe and Effective” Means for Medical AI
Future Doctor, a China-based AI healthcare technology company, together with 32 clinical experts, has published new research in Nature Portfolio’s npj Digital Medicine proposing a “Clinical Safety-Effectiveness Dual-Track Benchmark” (CSEDB). The framework is designed to measure whether medical AI systems are safe and effective in real-world clinical decision-making. A comparative evaluation of leading large language models, including OpenAI’s o3, Google’s Gemini 2.5 Pro, and Anthropic’s Claude 3.7 Sonnet, found the company’s own MedGPT scoring highest across all key categories.
